Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Breast Cancer × trastuzumab deruxtecan × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 51 Neoplasm Metastasis 20 Stomach Neoplasms 12 Carcinoma, Non-Small-Cell Lung 11 Colorectal Neoplasms 8 Neoplasms 7 Brain Neoplasms 7 Triple Negative Breast Neoplasms 5 Adenocarcinoma 5 Recurrence 3 Ovarian Neoplasms 3 Endometrial Neoplasms 3 Advanced Solid Tumor 3 Salivary Gland Neoplasms 2 Pancreatic Neoplasms 2 Meningeal Carcinomatosis 2 Esophageal Neoplasms 2 Uterine Neoplasms 1 Solid Cancer 1 Sarcoma 1 Prostatic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Neoplasm, Residual 1 Melanoma 1 Lung Neoplasms 1 HER2-positive Gastric Cancer 1 HER2-positive Breast Cancer 1 HER2-negative Breast Cancer 1 HER2-mutant Non-Small Cell Lung Cancer 1

Interventions

Fulvestrant 16 Letrozole 6 Capecitabine 5 Anastrozole 5 olaparib 4 Docetaxel 4 pyrotinib 3 palbociclib 3 Goserelin 3 sacituzumab govitecan 2 exemestane 2 Vinorelbine 2 Trastuzumab 2 Paclitaxel 2 FCN-437c 2 Dasatinib 2 Aromatase Inhibitors 2 Alpelisib 2 vandetanib 1 trastuzumab deruxtecan 1 talazoparib 1 sonidegib 1 neratinib 1 liposomal doxorubicin 1 irinotecan sucrosofate 1 eribulin 1 entinostat 1 elacestrant 1 disitamab vedotin 1 dalpiciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06486883 2026-03-02

PONTIAC

MedSIR

Phase 2 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡